| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
HC Wainwright & Co. analyst Ananda Ghosh maintains PepGen (NASDAQ:PEPG) with a Buy and raises the price target from $18 ...
HC Wainwright & Co. analyst Ananda Ghosh maintains PepGen (NASDAQ:PEPG) with a Buy and raises the price target from $12 ...
Wedbush analyst Laura Chico maintains PepGen (NASDAQ:PEPG) with a Outperform and lowers the price target from $9 to $8.
Gainers Indaptus Therapeutics (NASDAQ: INDP) stock moved upwards by 108.1% to $6.83 during Friday's regular session. The m...
Gainers bioAffinity Technologies (NASDAQ: BIAF) stock increased by 71.8% to $5.86 during Friday's pre-market session. The ...